Darbepoetin alfa biosimilar (Reliance Life Sciences)
阿法达贝泊汀生物类似药 (Reliance Life Sciences)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameDarbepoetin alfa biosimilar (Reliance Life Sciences)
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesReliance Life Sciences
China Registration ClassN/A
Develop Information
Active CompaniesReliance Life Sciences
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A